IntroductionBicuspid aortic valve (BAV) is a common congenital cardiac malformation, with a reported incidence of between 0.6% and 2% in the general population. 1,2) BAV has been identified as the main cause of aortic valve disease leading to surgical treatment in children and young adults. A large pathological survey revealed that BAV could result in a stenotic lesion in 75% of patients and insufficiency in 15%. 3) Although BAV is often considered to be a benign lesion early in life, the complications associated with cardiovascular diseases, including aortic stenosis (AS), aortic insufficiency (AI), infective endocarditis (IE), and aortic dilation and dissection, can result in marked increases in morbidity and mortality later in life. [4][5][6] Understanding of aortic dilation associated with BAV has evolved with improvements in diagnostic technology and surgical management. 7) There is a growing consensus that the ascending aorta should be replaced at the time of aortic valve replacement for bicuspid aortic valve even if it is only moderately dilated. A recent study that gathered information from a total of 100 Canadian cardiac surgeons reported that surgeons' knowledge and attitudes toward BAV aortopathy influenced their surgical approaches. This large survey revealed significant gaps in the knowledge and attitudes of surgeons toward the diagnosis and management of BAV aortopathy, with approximately one third of cardiac surgeons stating that